JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC
JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC
Active, not recruiting · NCT06944470 · Registry updated 2026-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC | non-small cell lung carcinoma | Active, not recruiting | Phase 2 | 2026-07-27 | NCT06944470 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Junshi Bioscience Co., Ltd. | 42 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guangdong Provincial People's Hospital | Guangzhou | China | 85 |